News
Zymenex hosts European Alpha-mannosidosis Disease Group meeting
Zymenex sells clinical candidate Metazym to Shire for 135 MUSD
Innovation for Quality of Life

We are engaged in the research and development of innovative therapeutics for life threatening diseases

Zymenex A/S Roskildevej 12 C
3400 Hillerød, DK
Tel  +45 48250054
Fax  +45 48251054
Affiliate Sweden Dalénum 13
181 70 Lidingö, S
Tel  +46 8 7670203
Fax  +46 8 7670233

© 2004 Zymenex A/S